Tag: worth-nearly
-
Novartis CEO plays down prospects for Actelion bid: Blick
Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson & Johnson about a transaction. Asked by Swiss Sunday newspaper SonntagsBlick whether Novartis could emerge as a white knight, he said: “We have always said that we…
-
Novartis CEO plays down prospects for Actelion bid: Blick
Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson & Johnson about a transaction. Asked by Swiss Sunday newspaper SonntagsBlick whether Novartis could emerge as a white knight, he said: “We have always said that we…
-
Players: Kerr’s marijuana admission could spark dialogue
OAKLAND, Calif. (AP) — David West has undergone four surgeries in his long NBA career: left knee, right elbow and right foot twice to fix a couple of toes.